FierceBiotech1d
Wave hails first for human RNA editing with GSK-partnered prospect, sending stock skyward
Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...
BioSpace1d
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals
When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...
Europe’s answer to the Magnificent Seven comes up short
Europe’s answer to the Magnificent Seven is leaving much to be desired after two of the Continent’s biggest companies, ASML Holding and LVMH Moet Hennessy, disappointed investors.
GSK's UTI Treatment Gets Accepted for Priority Review by U.S.'s FDA
GSK said that its urinary tract infections treatment gepotidacin has been accepted for priority review by the U.S.'s Food and Drug Administration.